Insulin aspart, recombinant Subcutaneous and Senna Plus
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Senna Plus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: docusate / senna
Brand name: Doc-Q-Lax, Doculax, Dok Plus, Gentlax S, Peri-Colace, Senna Plus, Senna S, Sennalax-S, Senokot S, SenoSol-SS, Medi-Laxx, Senna-Plus, Senna-S, Stool Softener/Laxative
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Senna S
- Insulin aspart, recombinant Subcutaneous-Senna-gen
- Insulin aspart, recombinant Subcutaneous-Senna-Time S
- Insulin aspart, recombinant Subcutaneous-Sennalax-S
- Insulin aspart, recombinant Subcutaneous-Sennosides Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Sennosides Chewable Tablets
- Senna Plus-Insulin degludec
- Senna Plus-Insulin Degludec (U-100) Prefilled Pens
- Senna Plus-Insulin Degludec (U-100) Vials
- Senna Plus-Insulin Degludec (U-200) Prefilled Pens
- Senna Plus-Insulin degludec and liraglutide
- Senna Plus-Insulin degludec and liraglutide Subcutaneous